Information  X 
Enter a valid email address

Broker Forecast - Morgan Stanley issues a broker note on GlaxoSmithKline PLC

By BFN News | 12:00 PM | Monday 06 January, 2020

Morgan Stanley today reaffirms its underweight investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1740p (from 1640p). Story provided by Broker Forecasts data provided by

a d v e r t i s e m e n t